share_log

Allarity Therapeutics | 424B5: Prospectus

Allarity Therapeutics | 424B5: Prospectus

Allarity Therapeutics | 424B5：募资说明书
SEC announcement ·  04/09 09:19
Moomoo AI 已提取核心信息
Allarity Therapeutics Inc. has filed a prospectus supplement on April 9, 2024, to increase the maximum aggregate offering price of its common stock from $947,000 to $1,350,000. This amendment is in accordance with the At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC. The company's public float was valued at approximately $4,052,088, with a closing stock price of $0.43 on February 9, 2024. Allarity Therapeutics has already sold $654,871 worth of common stock in the past 12 months and can sell up to an additional $695,825 under the current SEC guidelines. The company is restricted to selling no more than one-third of the aggregate market value of its common stock held by non-affiliates in any 12-month period, as long as the public float remains below $75 million.
Allarity Therapeutics Inc. has filed a prospectus supplement on April 9, 2024, to increase the maximum aggregate offering price of its common stock from $947,000 to $1,350,000. This amendment is in accordance with the At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC. The company's public float was valued at approximately $4,052,088, with a closing stock price of $0.43 on February 9, 2024. Allarity Therapeutics has already sold $654,871 worth of common stock in the past 12 months and can sell up to an additional $695,825 under the current SEC guidelines. The company is restricted to selling no more than one-third of the aggregate market value of its common stock held by non-affiliates in any 12-month period, as long as the public float remains below $75 million.
Allarity Therapeutics Inc.已于2024年4月9日提交了招股说明书补充文件，将其普通股的最高总发行价从94.7万美元提高至135万美元。该修正案符合与Ascendiant Capital Markets, LLC签订的市场发行销售协议。该公司的公众持股量约为4,052,088美元，2024年2月9日的收盘价为0.43美元。在过去的12个月中，Allarity Therapeutics已经出售了价值654,871美元的普通股，根据美国证券交易委员会目前的指导方针，最多可以再出售695,825美元的普通股。只要公众持股量保持在7,500万美元以下，该公司在任何12个月内出售的普通股总市值的三分之一都不得超过其非关联公司持有的普通股总市值的三分之一。
Allarity Therapeutics Inc.已于2024年4月9日提交了招股说明书补充文件，将其普通股的最高总发行价从94.7万美元提高至135万美元。该修正案符合与Ascendiant Capital Markets, LLC签订的市场发行销售协议。该公司的公众持股量约为4,052,088美元，2024年2月9日的收盘价为0.43美元。在过去的12个月中，Allarity Therapeutics已经出售了价值654,871美元的普通股，根据美国证券交易委员会目前的指导方针，最多可以再出售695,825美元的普通股。只要公众持股量保持在7,500万美元以下，该公司在任何12个月内出售的普通股总市值的三分之一都不得超过其非关联公司持有的普通股总市值的三分之一。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息